PND39 Socioeconomic Value of Ocrelizumab in the Treatment of Patients with Relapsing Remitting Multiple Sclerosis
Jun 1, 2021, 00:00
10.1016/j.jval.2021.04.823
https://www.valueinhealthjournal.com/article/S1098-3015(21)01040-8/fulltext
Title :
PND39 Socioeconomic Value of Ocrelizumab in the Treatment of Patients with Relapsing Remitting Multiple Sclerosis
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)01040-8&doi=10.1016/j.jval.2021.04.823
First page :
Section Title :
Open access? :
No
Section Order :
10329